Tellgen
1 known investors
Tellgen develops in vitro diagnostic products, including test kits for Y-chromosome microdeletion, HPV genotyping, tumor markers (AFP), and lung cancer methylation detection, along with automated chemiluminescence immunoassay and flow fluorescence analyzers. The company serves clinical and health-screening laboratories, with products tailored to Chinese epidemiological characteristics.
Investors · 1
Frequently asked questions
- What does Tellgen do?
- Tellgen develops in vitro diagnostic products, including test kits for Y-chromosome microdeletion, HPV genotyping, tumor markers (AFP), and lung cancer methylation detection, along with automated chemiluminescence immunoassay and flow fluorescence analyzers. The company serves clinical and health-screening laboratories, with products tailored to Chinese epidemiological characteristics.
- Who are Tellgen's investors?
- Tellgen's investors include Qiming Venture Partners.